|
IMPORTANT COVID-19 ATTENDEE POLICY – Please note, all attendees for the March BioBreakfast must be fully vaccinated and will need to show proof of vaccination upon arrival. If you are unable to provide proof of vaccination, you will not be permitted entrance to the event. All attendees must pre-register for the March BioBreakfast, walk-ins will not be accepted. At this time, masks are not required but attendees are welcome to wear a mask.
These policies are subject to change, and you will be notified via email if changes are made to the current policy.
March BioBreakfast
Wednesday, March 23, 2022
Our March BioBreakfast is back in-person! Join us Wednesday, March 23rd from 7:30 - 9:30 am at Incyte. It's been a while since many of us have been together for a BioBreakfast so we'll have plenty of time for coffee and conversation, then we'll hear an important update from Hervé Hoppenot on the exciting developments and innovation underway at Incyte.
Event Speakers
 |
| Hervé Hoppenot
|
| Chief Executive Officer |
| Incyte |
Hervé Hoppenot joined Incyte in 2014 as President and Chief Executive Officer, and was appointed Chairman of the Board of Directors in 2015.
During Mr. Hoppenot’s tenure, the Company has tripled the number of clinical candidates in its portfolio, expanding beyond oncology to include research and development in inflammation & autoimmunity. Under his leadership, revenue has increased by over 500 percent, which includes the addition of 5 new revenue sources of potential revenue; and, with a goal to deliver medicines to patients worldwide, the Company has expanded geographically beyond the U.S. to include operations in Canada, 10 European countries, Japan and China.
Prior to joining Incyte, Mr. Hoppenot was the President of Novartis Oncology. Prior to joining Novartis in 2003, Mr. Hoppenot started his career in 1983 with Rhone Poulenc, later known as Aventis, where he served in several senior roles of increasing responsibility, including Vice President of Oncology and Head of the U.S. Oncology business unit. Mr. Hoppenot holds a diploma from ESSEC Business School.
|
Why You Should Attend
- Hear from and meet with executives at the top life science companies making a difference here in Delaware
- Connect with new business opportunities
- Get the pulse on the latest life sciences trends
- Network with peers and potential partners
Registration Policy
The “In Transition” rate is available for first-time attendees seeking employment. If you are still searching for employment after the first BioBreakfast and wish to continue attending, we offer you a discounted rate of $25 to attend. The “Non-Member” rate is for those who very occasionally attend our events ( no more than two events) or for those who are evaluating whether they wish to join Delaware Bio. This is not intended for individuals who attend every event in a series. If you fall into this category, we ask that you join the organization. Information about membership can be found by contacting us at info@delawarebio.org.
Please note that Delaware Bio is a member-supported organization, preference is given to our members. If an event becomes sold out and you are registered as a non-member, we reserve the right to cancel your registration and refund your payment. If you are retired and wish to attend BioBreakfast, we ask that you join the organization as a member, at our new, discounted retired membership level.
When registering please use your company email address, so we can verify membership (if applicable). Registration for our virtual events will end 24-hours before the event is set to begin to ensure you receive the proper communication to join the event. Please register in advance, as it may fill up quickly. Thank you!
Refund Policy
Cancellations must be made in writing, via email to Yvette Murray more than one (1) week prior to the event to receive a refund minus 25% for registration/administrative costs. If the cancellation is made within one week of the event or the attendee is a no-show, Delaware Bio will not issue a refund. If you have any questions or concerns, please contact Yvette Murray.
|
Print Page